We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+7.77%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$5B
AUM Growth
+$283M
Cap. Flow
-$6.9M
Cap. Flow %
-0.14%
Top 10 Hldgs %
18.22%
Holding
1,507
New
129
Increased
613
Reduced
585
Closed
96

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$9.57M
2
AAPL icon
Apple
AAPL
+$7.32M
3
ABB
ABB Ltd
ABB
+$7.11M
4
NVDA icon
NVIDIA
NVDA
+$6.77M
5
ALL icon
Allstate
ALL
+$6.29M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Financials 10.19%
3 Healthcare 9.77%
4 Industrials 9.03%
5 Consumer Discretionary 7.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OC icon
1026
Owens Corning
OC
$11.2B
$439K 0.01%
+3,361
New +$368K
PII icon
1027
Polaris
PII
$3.82B
$438K 0.01%
3,624
+14
+0.4% +$1.55K
MFC icon
1028
Manulife Financial
MFC
$73.9B
$438K 0.01%
23,163
+13,089
+130% +$250K
NMFC icon
1029
New Mountain Finance
NMFC
$651M
$435K 0.01%
35,002
+4,739
+16% +$57.2K
FERG icon
1030
Ferguson
FERG
$45.4B
$435K 0.01%
+2,765
New +$394K
NWN icon
1031
Northwest Natural Holdings
NWN
$2.06B
$428K 0.01%
9,950
WPC icon
1032
W.P. Carey
WPC
$16.8B
$427K 0.01%
6,453
+2,994
+87% +$208K
IRM icon
1033
Iron Mountain
IRM
$36.4B
$425K 0.01%
7,481
+1,092
+17% +$59.8K
SPYG icon
1034
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$51.9B
$424K 0.01%
6,946
+1,821
+36% +$104K
VDC icon
1035
Vanguard Consumer Staples ETF
VDC
$7.97B
$422K 0.01%
2,169
+346
+19% +$67.6K
AYI icon
1036
Acuity Brands
AYI
$9.83B
$422K 0.01%
2,586
+750
+41% +$120K
USX
1037
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$422K 0.01%
+68,680
New +$416K
SPHB icon
1038
Invesco S&P 500 High Beta ETF
SPHB
$969M
$422K 0.01%
5,519
-3,694
-40% -$257K
STT icon
1039
State Street
STT
$50.6B
$420K 0.01%
5,739
+645
+13% +$46.4K
PSLV icon
1040
Sprott Physical Silver Trust
PSLV
$12B
$419K 0.01%
53,807
-175
-0.3% -$1.45K
SRPT icon
1041
Sarepta Therapeutics
SRPT
$1.57B
$419K 0.01%
3,655
+5
+0.1% +$645
MTD icon
1042
Mettler-Toledo International
MTD
$28.6B
$417K 0.01%
318
+37
+13% +$52K
ICE icon
1043
Intercontinental Exchange
ICE
$85.6B
$416K 0.01%
3,677
-127
-3% -$13.8K
KR icon
1044
Kroger
KR
$35.4B
$415K 0.01%
8,829
-7,438
-46% -$355K
SJNK icon
1045
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.89B
$415K 0.01%
16,782
-3,501
-17% -$85.9K
PXH icon
1046
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.94B
$414K 0.01%
22,200
+1,900
+9% +$35.2K
UFOX
1047
Defiance Space and Connective Tech ETF
UFOX
$835M
$411K 0.01%
12,216
CFLT
1048
DELISTED
Confluent
CFLT
$408K 0.01%
11,566
+160
+1% +$4.48K
PERI icon
1049
Perion Network
PERI
$375M
$407K 0.01%
13,274
+2,664
+25% +$91.5K
XAR icon
1050
State Street SPDR S&P Aerospace & Defense ETF
XAR
$5.93B
$406K 0.01%
3,343
+28
+0.8% +$3.25K

Similar funds

Oppenheimer & Co's Q2 2023 Portfolio in Review

As of Q2 2023, Oppenheimer & Co held 1,507 positions worth $5B, up 6% from $4.72B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Oppenheimer & Co's Q2 2023 filing shows 129 new, 613 increased, 585 reduced and 96 closed positions. Its largest new stake was Ovintiv: 88,415 shares worth $3.37M. The largest sale was Microsoft, an estimated $9.57M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Oppenheimer & Co's largest Q2 2023 buy was Ovintiv: 88,415 shares worth $3.37M.
  • Oppenheimer & Co added most to BlackBerry in Q2 2023, an estimated $5.12M increase.
  • Oppenheimer & Co's biggest Q2 2023 reduction was Microsoft, cutting an estimated $9.57M.
  • Oppenheimer & Co fully exited ABB Ltd in Q2 2023, selling an estimated $7.11M.
  • Oppenheimer & Co's ten largest holdings make up 18% of its $5B portfolio in Q2 2023.
  • Oppenheimer & Co opened 129 new positions and closed 96 in Q2 2023.
  • Oppenheimer & Co's portfolio value rose 6% quarter-over-quarter to $5B.

Based on Oppenheimer & Co's 13F filing for Q2 2023, filed 3 Aug 2023.